CLO25-067: Risk of Trastuzumab Deruxtecan (T-DXd) Associated Interstitial Lung Disease (ILD)/Pneumonitis: A Real-World Population-Based Propensity-Matched Analysis
"CLO25-067: Risk of Trastuzumab Deruxtecan (T-DXd) Associated Interstitial Lung Disease (ILD)/Pneumonitis: A Real-World Population-Based Propensity-Matched Analysis" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Piyush Nathani (ORCID: https://orcid.org/0000-0002-4316-414X)
- Rohit Nathani
- Parth Sharma (ORCID: https://orcid.org/0000-0002-0647-4691)
- Anuj Shrestha (ORCID: https://orcid.org/0000-0002-3502-6572)
Institutions
- The University of Kansas Health System (US)
- University of Missouri–Kansas City (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7223
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52